Dual FGF-2 and intergrin α5β1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy

Cancer Microenvironment

Volumn 2, Issue 1, 2009, Pages 33-47

  Barrios, Judith ^a   Wieder, Robert ^a  

^a New Jersey Medical School University Hospital Cancer Center   (United States)

Author keywords

Breast cancer; Dormancy; Fibronectin; GRAF; Integrin 5 1; Micrometastases; PI3 kinase; Rho GTPases

Indexed keywords

ACTIN; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; FOCAL ADHESION KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; BREAST CANCER; CELL SPREADING; CELL SURVIVAL; DORMANCY; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IN VITRO SELECTION; MEMBRANE; PATHOGENESIS; PERIMETER; PHENOTYPE; PRIORITY JOURNAL;

EID: 73449109119     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-009-0019-6     Document Type: Article

References (60)

1. S Braun K Pantel P Muller, et al. 2000 Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N Engl J Med 342 525 533 10.1056/NEJM200002243420801 1:STN:280: DC%2BD3c7jt1ejsw%3D%3D 10684910 (Pubitemid 30117892)
2. S Braun C Kentenich W Janni, et al. 2000 Lack of an effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high risk breast cancer patients J Clin Onc 18 80 86 1:CAS:528: DC%2BD3cXmtFSrsQ%3D%3D
3. R Korah M Boots R Wieder 2004 Integrin α5β1 promotes survival of breast cancer cells: an in vitro paradigm for breast cancer cell dormancy in the bone marrow Can Res 64 4514 4522 10.1158/0008-5472.CAN-03-3853 1:CAS:528:DC%2BD2cXltlOrsLg%3D (Pubitemid 38856923)
4. PL Nguyen AG Taghian MS Katz, et al. 2008 Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2373 2378 10.1200/JCO.2007.14.4287 18413639
5. BG Haffty Q Yang M Reiss, et al. 2006 Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 5652 5657 10.1200/JCO.2006.06.5664 17116942 (Pubitemid 46631305)
6. R Dent M Trudeau KI Pritchard, et al. 2007 Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 15 Pt 1 4429 4434 10.1158/1078-0432.CCR-06-3045 17671126 (Pubitemid 47219710)
7. M Cazzaniga P Pronzato SL Leto di Priolo, et al. 2004 Patterns of relapse and modalities of treatment of breast cancer: the 'IRIS' Project, a multicenter observational study Oncology 66 260 268 10.1159/000078325 1:STN:280: DC%2BD2czhs1Ojsg%3D%3D 15218292 (Pubitemid 38822795)
8. A Nicolini R Giardino A Carpi, et al. 2006 Metastatic breast cancer: an updating Biomedicine & Pharmacotherapy 60 548 556 10.1016/j.biopha.2006.07. 086 1:STN:280:DC%2BD28nptlKrtw%3D%3D (Pubitemid 44635086)
9. SK Nilsson ME Debatis MS Dooner, et al. 1998 Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ J Histochem & Cytochem 46 371 377 1:CAS:528:DyaK1cXhsVKhtb0%3D
10. D Van der Velde-Zimmermann MA Verdaasdonk LH Rademakers, et al. 1997 Fibronectin distribution in human bone marrow stroma: matrix assembly and tumor cell adhesion via α5β1 integrin Exp Cell Res 230 111 120 10.1006/excr.1996.3405 9013713 (Pubitemid 27187546)
11. A Balduino SP Hurtado P Frazao, et al. 2005 Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations Cell & Tissue Research 319 255 266 10.1007/s00441-004-1006-3 (Pubitemid 40174519)
12. B Psaila RN Kaplan ER Port, et al. 2006 Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche Breast Disease 26 65 7413 1:CAS:528:DC%2BD2sXksVCjt78%3D 17473366
13. Sinowatz F, Schams D, Plath A et al (2000) Expression and localization of growth factors during mammary gland development. In: Mol JA, Clegy RA (eds) Biology of the Mammary Gland. Kluwer Acad, New York, pp 19-25
14. 1 events Cancer Res 57 1750 1757 1:CAS:528:DyaK2sXjtFeltr4%3D 9135019
15. R Korah V Sysounthone E Scheff, et al. 2000 Intracellular FGF-2 promotes differentiation in T47-D breast cancer cells Biochem Biophys Res Comm 277 255 260 10.1006/bbrc.2000.3655 1:CAS:528:DC%2BD3cXntFOqu7w%3D 11027671 (Pubitemid 30796369)
16. R Korah V Sysounthone Y Golowa, et al. 2000 Basic fibroblast growth factor confers a more differentiated phenotype in MDA-MB-231 human breast cancer cells Cancer Res 60 733 740 1:CAS:528:DC%2BD3cXht1Gmur8%3D 10676661
17. R Wieder E Fenig H Wang, et al. 1998 Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation J. Cellular Physiology 177 411 425 10.1002/(SICI)1097-4652(199812)177:3<411::AID-JCP5>3.0.CO;2-Y 1:CAS:528:DyaK1cXnsVGqu7g%3D (Pubitemid 28524665)
18. G Brunner H Nguyen J Gabrilove, et al. 1993 Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells Blood 81 631 638 1:CAS:528:DyaK3sXhs1Wgurk%3D 8427958 (Pubitemid 23040853)
19. SY Yoon CY Li RV Lloyd, et al. 2000 Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodisplastic syndrome with myelofibrosis and related disorders Int J Hematol 72 337 342 1:CAS:528:DC%2BD3MXhsVGqsw%3D%3D 11185990
20. G Brunner J Gabrilove DB Rifkin, et al. 1991 Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan J Cell Biol 114 1275 1283 10.1083/jcb.114.6.1275 1:CAS:528:DyaK3MXlslGgtrc%3D 1654337
21. JL Gabrilove K White Z Rahman, et al. 1993 Stem cell factor and basic fibroblast growth factor are synergistic in augmenting commited myeloid progenitor cell growth Blood 83 907 910
22. G Brunner CN Metz H Nguyen, et al. 1994 An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures Blood 83 2115 2125 1:CAS:528:DyaK2cXis1WksLk%3D 8161780
23. AR Howlett N Bailey C Damsky, et al. 1995 Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma J Cell Sci 108 Pt 5 1945 1957 1:CAS:528:DyaK2MXls1Olt78%3D 7544798
24. LM Shaw 1999 Integrin function in breast carcinoma progression J Mammary Gland Biol & Neoplasia 4 367 376 10.1023/A:1018766317055 1:STN:280:DC%2BD3c7mvVCgtQ%3D%3D
25. GP Gui CA Wells P Yeomans, et al. 1996 Integrin expression in breast cancer cytology: a novel predictor of axillary metastasis European J Surgical Oncol 22 254 258 10.1016/S0748-7983(96)80013-8 1:STN:280:DyaK283mvVeluw%3D%3D (Pubitemid 26229675)
26. S Najmi R Korah R Chandra, et al. 2005 Flavopiridol blocks integrin-mediated survival in dormant breast cancer cells Clin Can Res 11 2038 2046 10.1158/1078-0432.CCR-04-1083 1:CAS:528:DC%2BD2MXitVKrtr4%3D (Pubitemid 40471870)
27. R Korah L Choi J Barrios, et al. 2004 Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells Breast Cancer Res Treat 88 17 28 10.1007/s10459-004-6006-2 1:CAS:528: DC%2BD2cXpsF2mtrk%3D 15538042 (Pubitemid 39524441)
28. SI Ellenbroek JG Collard 2007 Rho GTPases: functions and association with cancer Clinical & Experimental Metastasis 24 657 672 10.1007/s10585-007- 9119-1 1:CAS:528:DC%2BD1cXhvFGgtrs%3D (Pubitemid 50002983)
29. WG Jiang G Watkins J Lane, et al. 2003 Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers Clinical Cancer Res 9 6432 6440 1:CAS:528:DC%2BD3sXhtVSqurrK
30. P Maloof Q Wang H Wang, et al. 1999 Overexpression of retrovirally transduced basic FGF in MCF-7 human breast cancer cells downregulates Bcl-2 and sensitizes cells to chemotherapy-induced apoptosis Breast Cancer Res Treatment 56 153 167 1:CAS:528:DyaK1MXnvVKitrw%3D
31. I Whitehead H Kirk C Tognon, et al. 1995 Expression cloning of lfc, a novel oncogene with structural similarities to guanine nucleotide exchange factors and to the regulatory region of protein kinase C J Biol Chem 270 18388 18395 10.1074/jbc.270.31.18388 1:CAS:528:DyaK2MXntlCqtLY%3D 7629163
32. PL Rodriguez S Sahay OO Olabisi, et al. 2007 ROCK I-mediated activation of NF-kappaB by RhoB Cellular Signalling 19 2361 2369 10.1016/j.cellsig.2007.07. 021 1:CAS:528:DC%2BD2sXhtVWmtbrF 17728102 (Pubitemid 47361690)
33. C Zhong MS Kinch K Burridge 1997 Rho-stimulated contractility contributes to the fibroblastic phenotype of Ras transformed epithelial cells Mol Biol Cell 8 2329 2344 1:CAS:528:DyaK2sXntFyruro%3D 9362072
34. SK Mitra DD Schlaepfer 2006 Integrin-regulated FAK-Src signaling in normal and cancer cells Current Opinion in Cell Biology 18 516 23 10.1016/j.ceb.2006.08.011 1:CAS:528:DC%2BD28XpsVOjtL8%3D 16919435 (Pubitemid 44332916)
35. WG Cance JE Harris MV Iacocca, et al. 2000 Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes Clin Cancer Res 6 2417 2423 1:CAS:528:DC%2BD3cXksVGhsLY%3D 10873094
36. AL Lark CA Livasy L Dressler, et al. 2005 High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype Modern Pathol 18 1289 1294 10.1038/modpathol.3800424 1:CAS:528:DC%2BD2MXhtVWiu7bL (Pubitemid 41348647)
37. HJ Lin FC Hsieh H Song, et al. 2005 Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer British J Cancer 93 1372 1381 10.1038/sj.bjc.6602862 1:CAS:528:DC%2BD2MXht1yju7jM (Pubitemid 41752864)
38. MJ van Nimwegen S Verkoeijen L van Buren, et al. 2005 Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation Cancer Res 65 4698 4706 10.1158/0008-5472.CAN-04-4126 15930288 (Pubitemid 40740806)
39. DO Watermann B Gabriel M Jager, et al. 2005 Specific induction of pp125 focal adhesion kinase in human breast cancer British J. Cancer 93 694 698 10.1038/sj.bjc.6602744 1:CAS:528:DC%2BD2MXhtV2kt73F (Pubitemid 41486461)
40. R Korah K Das ME Lindy, et al. 2007 Co-ordinate loss of FGF-2 and laminin 5 expression during neoplastic progression of mammary duct epithelium Human Pathology 38 154 160 10.1016/j.humpath.2006.07.004 1:CAS:528:DC%2BD28XhtleisrfP 16996573 (Pubitemid 44880211)
41. A Borkhardt S Bojesen OA Haas, et al. 2000 The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q Proc Natl Acad Sci USA 97 9168 9173 10.1073/pnas.150079597 1:CAS:528: DC%2BD3cXls12ksL8%3D 10908648 (Pubitemid 30626692)
42. JD Hildebrand JM Taylor JT Parsons 1996 An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase Molecular & Cellular Biology 16 3169 3178 1:CAS:528: DyaK28XjtFCqt7k%3D
43. JM Taylor MM Macklem JT Parsons 1999 Cytoskeletal changes induced by GRAF, the GTPase Associated with Focal Adhesion Kinase, are mediated by Rho J Cell Sci 112 231 242 1:CAS:528:DyaK1MXhtlyhsrw%3D 9858476
44. KL Longenecker B Zhang U Derewenda, et al. 2000 Structure of the BH domain from Graf and its implications for Rho GTPase recognition J Biol Chem 275 38605 38610 10.1074/jbc.M007574200 1:CAS:528:DC%2BD3cXoslymtLw%3D 10982819 (Pubitemid 32009189)
45. H Shibata K Oishi A Yamagiwa, et al. 2001 PKNbeta interacts with the SH3 domains of Graf and a novel Graf related protein, Graf2, which are GTPase activating proteins for Rho family J Biochem 130 23 31 1:CAS:528: DC%2BD3MXmt12mu7g%3D 11432776
46. PJ Sheffield U Derewenda J Taylor, et al. 1999 Expression, purification and crystallization of a BH domain from the GTPase regulatory protein associated with focal adhesion kinase Acta Crystallographica Section D-Biological Crystallography 55 Pt 1 356 359 10.1107/S0907444998009032 1:STN:280: DyaK1M3ktFOnsw%3D%3D
47. KJ Simpson AS Dugan AM Mercurio 2004 Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma Cancer Res 64 8694 8701 10.1158/0008-5472.CAN-04-2247 1:CAS:528:DC%2BD2cXhtVCjs7rJ 15574779 (Pubitemid 39552085)
48. AY Chan SJ Coniglio YY Chuang, et al. 2005 Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion Oncogene 24 7821 7829 10.1038/sj.onc. 1208909 1:CAS:528:DC%2BD2MXht1GisL3K 16027728 (Pubitemid 41715188)
49. B Karakas KE Bachman BH Park 2006 Mutation of the PIK3CA oncogene in human cancers Br J Cancer 94 455 459 10.1038/sj.bjc.6602970 1:CAS:528: DC%2BD28Xhs1ers70%3D 16449998 (Pubitemid 43289745)
50. N Maruyama Y Miyoshi T Taguchi, et al. 2007 Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women Clin Cancer Res 13 408 414 10.1158/1078-0432.CCR-06-0267 1:CAS:528:DC%2BD2sXoslSmtg%3D%3D 17202311 (Pubitemid 46225343)
51. M Barbareschi F Buttitta L Felicioni, et al. 2007 Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas Clin Cancer Res 13 6064 6069 10.1158/1078-0432.CCR-07-0266 1:CAS:528:DC%2BD2sXhtFygs7nL 17947469 (Pubitemid 350075063)
52. SY Li M Rong F Grieu, et al. 2006 PIK3CA mutations in breast cancer are associated with poor outcome Breast Cancer Res Treat 96 91 95 10.1007/s10549-005-9048-0 1:CAS:528:DC%2BD28XivVensbk%3D 16317585
53. JD Carpten AL Faber C Horn, et al. 2007 A transforming mutation in the pleckstrin homology domain of AKT1 in cancer Nature 448 439 444 10.1038/nature05933 1:CAS:528:DC%2BD2sXotFajtbk%3D 17611497 (Pubitemid 47123510)
54. C Blanco-Aparicio O Renner JF Leal, et al. 2007 PTEN, more than the AKT pathway Carcinogenesis 28 1379 1386 10.1093/carcin/bgm052 1:CAS:528: DC%2BD2sXos12ju78%3D 17341655 (Pubitemid 47243536)
55. HA Coller L Sang JM Roberts 2006 A new description of cellular quiescence Plos Biology 4 e83 10.1371/journal.pbio.0040083 16509772
56. E Fenig Y Kanfi Q Wang, et al. 2001 Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factor Breast Cancer Res Treat 70 27 37 10.1023/A:1012522321762 1:CAS:528:DC%2BD38XmtVKmuw%3D%3D 11767002 (Pubitemid 33105100)
57. JT Buijs NV Henriquez PG van Overveld, et al. 2007 TGF-beta and BMP7 interactions in tumour progression and bone metastasis Clinical & Experimental Metastasis 24 609 617 10.1007/s10585-007-9118-2 1:CAS:528:DC%2BD1cXhvFGgtr8%3D (Pubitemid 50003597)
58. JT Buijs NV Henriquez G van der Horst, et al. 2007 Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer Cancer Res 67 8742 8751 10.1158/0008-5472.CAN-06-2490 1:CAS:528: DC%2BD2sXhtVCit7vK 17875715 (Pubitemid 47437450)
59. H Allgayer JA Aguirre-Ghiso 2008 The urokinase receptor (u-PAR)-a link between tumor cell dormancy and minimal residual disease in bone marrow? APMIS 116 602 614 10.1111/j.1600-0463.2008.00997.x 1:CAS:528:DC%2BD1cXht1Cjsb7F 18834405
60. D Barkan H Kleinman JL Simmons, et al. 2008 Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68 6241 6250 10.1158/0008-5472.CAN-07-6849 1:CAS:528:DC%2BD1cXpt1Wjs7w%3D 18676848